| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |